Eli Lilly and Company (LLY) NYSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 965.06B |
| Enterprise Value | 1T |
| P/E Ratio | 39.23 |
| PEG Ratio | 0.42 |
| Price/Sales Ratio | 13.84 |
| Price/Book Ratio | 30.85 |
| Enterprise/Revenue | 14.42 |
| Enterprise/EBITDA | 32.63 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0.34 |
| Operating Margin | 0.44 |
| Return On Assets | 0.19 |
| Return On Equity | 0.93 |
| Revenue | 65.18B |
| Revenue/Share | 89.27 |
| Gross Profit | 54.62B |
| EBITDA | 27.94B |
| Net Income | 20.64B |
| Diluted EPS | 22.95 |
| Total Cash | 8.95B |
| Total Cash/Share | 10.03 |
| Total Debt | 54.91B |
| Total Debt/Equity | 1.62 |
| Current Ratio | 1.35 |
| Book Value Per Share | 37.96 |
| 52-Week Change | 59.19 |
| 52-Week High | 1,292.65 |
| 52-Week Low | 712.05 |
| Moving Average 50 Days | 1,189.16 |
| Moving Average 200 Days | 1,061.33 |
| Average Volume | 2.89M |
| Shares Outstanding | 941.74M |
| % Held by Institutions | 251.8 |
| Trailing Annual Dividend Rate | 6.69 |
| Trailing Annual Dividend Yield | 0.57 |
| Payout Ratio | 0.22 |
| Last Split Factor | 2:1 |
| Last Split Date | October 16, 1997 |